Cann Group
- Short interest
- <0.01%
- −4.39 pp 30d
- as of 23 Oct 2026
- Reported shorts
- 262
- Shares on issue
- 1.661B
Cann Group (ASX:CAN) had <0.01% of shares reported as short positions as of 23 Oct 2026, representing 262 shares. Cann Group operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Cann Group is an Australian pharmaceutical company focused on cultivating cannabis for medicinal and research purposes. They manufacture medicinal cannabis products, aiming to be a national benchmark for R&D and production processes. The company strives to improve the quality of life for patients through ethical leadership in the emerging medical cannabis industry.
Company profile →Cann Group (ASX:CAN) has <0.01% of its shares on issue reported as short positions as of 23 Oct 2026, or about 262 shares. Over the past 30 days that figure has fallen 4.39 percentage points, and over 90 days it has fallen 4.39 percentage points. Its highest recorded short interest was 4.43% in December 2025. CAN is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 46, 2026.
How each stock picker strategy reads CAN today
Prices to 18 Nov 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
Who holds CAN, as its notices state it
1 holder, 1 interest counted once, disclose 9.27% between them; largest: s Noble Investments Superannuation Fund Pty Ltd 9.27% as at (10 mo)
Notices read to · what the notices disclose, not a share of the company · Not financial advice · Report an errorFull register →
In the year to 30 Jun 2026, Cann Group (ASX:CAN) recorded revenue of A$8.6M and net profit after tax of A$20.6M. A year earlier it recorded revenue of A$13.2M and a net loss after tax of A$22.3M. Year-on-year growth: revenue −35.4% (FY). Net margin 240.9% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance and ASX (Markit), as at 13 Nov 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
asx · 17 Nov 2026
asx · 17 Nov 2026
asx · 17 Nov 2026
website
Other shorted stocks in this sector
Be the first to discuss CAN
Start a research thread or post the first pulse update
website
address